Parkinson's drug tested to save Diabetics' eyesight
NCT ID NCT07444892
Summary
This study tested whether levodopa, a medication used for Parkinson's disease, could help protect the retina in people with diabetes before visible eye damage occurs. Researchers gave 230 participants either placebo or different doses of levodopa for six months to find the best dosing schedule. They measured electrical activity in the retina and took detailed eye scans to see if the drug could prevent or slow early diabetic eye damage.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC RETINOPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Atlanta VA Medical Center
Decatur, Georgia, 30033, United States
Conditions
Explore the condition pages connected to this study.